The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Immunosuppressive CD14+HLA‐DRlow/− monocytes in prostate cancer
Open accessAbstract
OBJECTIVE: To determine if the levels of circulating myeloid‐derived suppressor cells increase with progression of prostate cancer (PCa); to determine if such cells could contribute to the relative inefficiency of PCa immunotherapy. MATERIALS AND METHODS: We analyzed peripheral blood mononuclear cells isolated from untreated PCa patients (uPCa; N = 18; mean age ± SD: 72.1 ± 6.9 years), tPCa (N = 22; 72.8 ± 9.8 years) and age matched controls (AMC; N = 12; 68.8 ± 7.5 years). We quantified surface marker phenotype, differentiation potential, effects on T cell proliferation and intracellular cytokines. RESULTS: We observed an unexpectedly high percentage of a type of myeloid‐derived suppressor cells, CD14+HLA‐DR low/− monocytes, in tPCa (30.7 ± 15.0% of CD14+ cells) relative to AMC (4.1 ± 6.5%, P < 0.0001) and uPCa (10.6 ± 14.3%, P = 0.0001). The levels of CD14+ HLA‐DR low/− cells were significantly correlated with circulating PSA levels and treatment with LHRH‐agonist leuprolide in combination with either an antiandrogen or dexamethasone. Monocytes from tPCa inhibited autologous T cell proliferation statistically significantly more effectively than AMC monocytes and were defective in their ability to differentiate into phenotypically mature dendritic cells. Isolated CD14+HLA‐DR low/− cells expressed higher levels of intracellular interleukin‐10 and suppressed T cell proliferation more effectively than isolated CD14+HLA‐DR+ cells. CONCLUSIONS: This is the first report of CD14+ cells exhibiting reduced expression of HLA‐DR molecules in PCa patients. These cells suppress immune cell function in vitro and, plausibly, in vivo, a finding that must be factored into the design of immunotherapy protocols for PCa patients. Prostate 70: 443–455, 2010. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
CD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/macrophages
Tiemessen, M. M., Jagger, A. L., Evans, H. G., van Herwijnen, M. J. C., John, S., & Taams, L. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706832104 · Cited by 852
Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793
SERAFINI, P., BORRELLO, I., & BRONTE, V (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 762
Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421
Kyprianou, N., & Isaacs, J. T. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-10-1515 · Cited by 410
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway
Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Krüger, C., Bachmann, O., Westendorf, A. M., Buer, J., Liblau, R., Manns, M. P., Korangy, F., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.032 · Cited by 311
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Drake, C. G., Doody, A. D. H., Mihalyo, M. A., Huang, C.-T., Kelleher, E., Ravi, S., Hipkiss, E. L., Flies, D. B., Kennedy, E. P., Long, M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.027 · Cited by 289
Hartigan-O'Connor, D. J., Poon, C., Sinclair, E., & McCune, J. M. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.10.008 · Cited by 289
Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells
Taams, L. S., van Amelsfort, J. M. R., Tiemessen, M. M., Jacobs, K. M. G., de Jong, E. C., Akbar, A. N., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.006 · Cited by 289
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 285
Augmentation of T cell levels and responses induced by androgen deprivation
Roden, A. C., Moser, M. T., Tri, S. D., Mercader, M., Kuntz, S. M., Dong, H., Hurwitz, A. A., McKean, D. J., Celis, E., Leibovich, B. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6098 · Cited by 276
Loercher, A. E., Nash, M. A., Kavanagh, J. J., Platsoucas, C. D., & Freedman, R. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6251 · Cited by 173
Monocyte Human Leukocyte Antigen–DR Transcriptional Downregulation by Cortisol during Septic Shock
Le Tulzo, Y., Pangault, C., Amiot, L., Guilloux, V., Tribut, O., Arvieux, C., Camus, C., Fauchet, R., Thomas, R., & Drénou, B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1329oc · Cited by 166
Yokokawa, J., Cereda, V., Remondo, C., Gulley, J. L., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2056 · Cited by 155
CYTOKINE VARIATIONS IN PATIENTS WITH HORMONE TREATED PROSTATE CANCER
Wise, G. J., Marella, V. K., Talluri, G. S., & Shirazian, D. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67289-8 · Cited by 152
Aragon‐Ching, J. B. (2007) · Frontiers in bioscience · doi:10.2741/2441 · Cited by 137
Reprogramming of circulatory cells in sepsis and SIRS
Cavaillon, J. M., Adrie, C., Fitting, C., & Adib‐Conquy, M. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x58733 · Cited by 132
Macrophage diversity and polarization: in vivo veritas
Mantovani, A. (2006) · Blood · doi:10.1182/blood-2006-05-019430 · Cited by 128
Wang, S., Hong, S., Yang, J., Qian, J., Zhang, X., Shpall, E. J., Kwak, L. W., & Yi, Q. (2006) · Blood · doi:10.1182/blood-2006-04-016980 · Cited by 96
Tumor escape mechanisms in prostate cancer
Miller, A. M., & Pisa, P. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0110-x · Cited by 83
Wolk, K., Kunz, S., Crompton, N. E. A., Volk, H., & Sabat, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207714200 · Cited by 74
Degl'Innocenti, E., Grioni, M., Capuano, G., Jachetti, E., Freschi, M., Bertilaccio, M. T. S., Michelini, R. H., Doglioni, C., & Bellone, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2429 · Cited by 64
Myeloid-derived suppressor cells: A novel therapeutic target
Ko, J. S., Bukowski, R. M., & Finke, J. H. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0014-6 · Cited by 61
Ugurel, S., Uhlig, D., Pf�hler, C., Tilgen, W., Schadendorf, D., & Reinhold, U. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0489-1 · Cited by 52
Paradigm Shifts in Cancer Vaccine Therapy
Schlom, J., Gulley, J. L., & Arlen, P. M. (2008) · Experimental Biology and Medicine · doi:10.3181/0708-mr-226 · Cited by 46
Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients
Torisu‐Itakura, H., Lee, J. H., Huynh, Y., Ye, X., Essner, R., & Morton, D. L. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318158795b · Cited by 43
Immunotherapy with dendritic cells for prostate cancer
Kaskel, A.-K., Waller, C. F., Schultze‐Seemann, W., & Veelken, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22859 · Cited by 38
Hernández, J. J. C., Almeida, M. D. G., Burgo, R. M., Hernández, P., Miralles, J. M., & Órfão, A. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.09.006 · Cited by 37
Hoffman, J. A., Weinberg, K. I., Azen, C., Horn, M. V., Dukes, L., Starnes, V. A., & Woo, M. S. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00069.x · Cited by 36
Dietz, A. B., Bulur, P. A., Erickson, M. R., Wettstein, P. J., Litzow, M. R., Wyatt, W. A., Dewald, G. W., Tefferi, A., Pankratz, V. S., & Vuk‐Pavlović, S. (2000) · Stem Cells and Development · doi:10.1089/152581600319676 · Cited by 35
Self-citationIs the measurement of monocytes HLA-DR expression useful in patients with sepsis?
Fumeaux, T., & Pugin, J. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0205-7 · Cited by 31
Aalamian, M., Chatta, G. S., Shurin, M. R., Huland, E., Huland, H., & Shurin, G. V. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_18 · Cited by 24
Exploiting Regulatory T-cell Populations for the Immunotherapy of Cancer
van der Vliet, H. J., Koon, H. B., Atkins, M. B., Balk, S. P., & Exley, M. A. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31805ca058 · Cited by 20
Corthay, A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-34814-8_14 · Cited by 15
Adherent Suppressor Cells in the Blood of Patients with Bladder Cancer
Herr, H. W. (1981) · The Journal of Urology · doi:10.1016/s0022-5347(17)54574-7 · Cited by 10
Cited by
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Metadata
- Authors
- Vuk‐Pavlović, S., Bulur, P. A., Lin, Y., Qin, R., Szumlanski, C. L., Zhao, X., & Dietz, A. B.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2009-11-09
- Volume
- 70
- Issue
- 4
- Pages
- 443-455
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2031200699
- Cited by
- 266
- References
- 43
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.